Related Experiment Video
Updated: Aug 31, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Can we get out of the COVID pandemic without adequate vaccination coverage in the pediatric population?
Susanna Esposito1, Rosanna Giordano2, Giulia Paini2
1Department of Medicine and Surgery, Pediatric Clinic, University of Parma, Via Gramsci 14, 43126, Parma, Italy. susanna.esposito@unimi.it.
Insights
Pediatric COVID-19 cases remained low until November 2021, then sharply increased, especially in unvaccinated children. Higher vaccination coverage in children is crucial to control the pandemic.
Area of Science:
- Epidemiology
- Pediatrics
- Infectious Diseases
Background:
- Children showed lower severe COVID-19 (Coronavirus Disease 2019) risk during early pandemic waves.
- Pediatric COVID-19 cases and transmission appeared minimal compared to adults.
Purpose of the Study:
- To conduct epidemiological surveillance of COVID-19 incidence and hospitalization in children.
- To highlight the importance of pediatric COVID-19 vaccination coverage.
Main Methods:
- Retrospective analysis of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infections in children in Parma, Italy (February 2020 - January 2022).
- Diagnosis confirmed via RT-PCR (real-time reverse-transcriptase polymerase-chain-reaction) testing.
Main Results:
- COVID-19 incidence in children was low until October 2021, then significantly increased with the Delta variant.
- The highest hospitalization rate was observed in children under 5, who are not yet eligible for vaccination.
- Vaccination coverage varied, with lower rates in younger children (5-11 years) and incomplete booster doses in adolescents (11-17 years).
Conclusions:
- A higher proportion of children and adolescents remain susceptible to SARS-CoV-2 compared to adults.
- Unvaccinated pediatric populations may contribute to the ongoing COVID-19 pandemic.
- Increased COVID-19 vaccination coverage in pediatric populations is essential to mitigate the pandemic's impact.
Background:
During the first and second COVID-19 pandemic waves, children, despite susceptible to SARS-CoV-2 infection, appeared at lower risk of severe disease, hospitalization, and death than adults and the elderly. Moreover, they seemed to play a minor role in the diffusion of the virus. The aim of this manuscript is to show epidemiological surveillance on COVID-19 incidence and hospitalization in the pediatric cohort in order to explain the importance of an adequate COVID-19 vaccination coverage in the pediatric population.
Methods:
All subjects with documented SARS-CoV-2 infection diagnosed in Parma, Italy, between February 21st, 2020, and January, 31st, 2022, were recruited in this epidemiological surveillance. Diagnosis of infection was established in presence of at least one respiratory specimen positive for SARS-CoV-2 nucleic acid using a validated real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assay.
Results:
The number of COVID-19 pediatric cases remained very low and lower than that recorded in the general population between early February 2020 and the end of October 2021, despite in the last part of this period the Delta variant emerged. On the contrary, starting from November 2021, a sharp and significant increase in COVID-19 incidence in the pediatric population was evidenced. This was detected in all the age groups, although greater in the populations aged 5-11 and 12-17 years old. Interestingly, the peak in hospitalization rate was observed in children < 5 years old, for whom COVID-19 vaccination is not approved yet. At the beginning of November 2021 among people older than 18 years of age 85.7% had completed the primary series of COVID-19 vaccine. Almost all the infants and pre-school children were susceptible. Until January 31st, 2022, 80.4% of adolescents aged 11-17 years had received at least two doses of COVID-19 vaccine and only 52.4% received the booster. Among children 5-11 years old, on January 31st, 2022, only 28.5% had received at least one vaccine dose.
Conclusions:
Compared with adults and the elderly, presently a greater proportion of children and adolescents is susceptible to SARS-CoV-2 and could play a relevant role for the prolongation of the COVID-19 pandemic. Only a rapid increase in vaccination coverage of the pediatric populations can effectively counter this problem.
More Related Videos
Related Concept Videos
Vaccinations
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Microorganisms in Medicine and Therapeutics
Pneumonia III: Complications and Assessment

